Lisa J Hwong, MD
Diagnostic Radiology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 8
- 4 carriers
- Offices
- 3
Offices
3 locations · Foundation Radiology Group PC · El Camino Health Medical Network LLC
Hospitals listed: El Camino Health · Upmc Williamsport. That is not proof they admit you there this week.
Plans that list them
8 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Hwong’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
8 of 8 plans
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G84844 · Current
Licensed to practise in California · since 1998 · expires 2027-12-31 · Boston University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Upmc WilliamsportWilliamsport, PAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of UPMC, which runs 34 hospitals in 3 statesPatients rate it 4 of 5 · 71% would definitely recommend itOverall rating: 3 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.38 (1.05 to 1.7), Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.63 (0.92 to 2.33) · 4,478 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.445, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.312, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Upmc Williamsport
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 3 the same, 1 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.38 (1.05 to 1.7) | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.63 (0.92 to 2.33) · 4,478 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.445 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.312 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.09 (0.11 to 2.07) · 1,048 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 210.48 (159.21 to 261.75) · 83 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 73 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.6 · 108 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 14.1 · 202 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 14 · 319 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 18.5 · 414 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.8 · 220 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 3,180 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.3 (0.1 to 0.5) · 5,403 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.42) · 5,460 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.53 (2.49 to 6.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.42 (0 to 3.02) · 553 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.65 (1.18 to 4.13) · 1,357 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.17 (3.56 to 16.78) · 566 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.02 (2.27 to 9.77) · 528 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.62 (0.15 to 3.09) · 284 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 101 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.33 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.052 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.8 · 353 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.9 · 632 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -4 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 3.5 · 427 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 742 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.6 (3.9 to 7.9) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.8 (7.3 to 12.8) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.8 · 105 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.8 · 109 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.8 · 225 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.1 (9.3 to 15.8) · 1,374 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.1) · 723 cases | No different | Jan 2024 – Dec 2024 |
What patients said (497 patients answered, 29% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 77% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 82% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 80% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$123,006
Medicare paid this office $123,006 for 917 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Screening mammography | 327 | $55,477 | $170 |
| Dxa bone density measurement of hip, pelvis, spine | 417 | $21,612 | $52 |
| Screening 3d breast mammography | 269 | $17,598 | $65 |
| Diagnostic mammography of 1 breast | 38 | $4,544 | $120 |
| Screening mammography | 95 | $3,843 | $40 |
See all 13 services
| Screening mammography | 327 | $55,477 | $170 |
| Dxa bone density measurement of hip, pelvis, spine | 417 | $21,612 | $52 |
| Screening 3d breast mammography | 269 | $17,598 | $65 |
| Diagnostic mammography of 1 breast | 38 | $4,544 | $120 |
| Screening mammography | 95 | $3,843 | $40 |
| Limited ultrasound scan of 1 breast | 43 | $3,494 | $79 |
| Screening 3d breast mammography | 74 | $2,351 | $32 |
| Complete ultrasound scan of abdomen | 20 | $2,265 | $113 |
| Diagnostic mammography of both breasts | 14 | $2,254 | $161 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 39 | $1,834 | $47 |
| Dxa bone density measurement of hip, pelvis, spine | 35 | $371 | $11 |
| X-ray of chest, 2 views | 23 | $322 | $14 |
| X-ray of foot, minimum of 3 views | 12 | $288 | $18 |
Who their Medicare patients are
917 Original Medicare patients in 2024. Average age 75 · Under 65 3% · 85 and older 13% · Women 85% · Also on Medicaid 11% · Health risk score 0.92. At or below the middle of the specialty; the typical diagnostic radiology clinician is at 1.7.
Conditions among them: High blood pressure 70% · Diabetes 27% · Coronary heart disease 17% · Chronic kidney disease 17% · Depression 14% · Cancer 13% · Atrial fibrillation 12% · Heart failure 8% · COPD 8% · Stroke 6% · Dementia 5%.
The office billed $446,474, Medicare allowed $134,128 and paid $123,006; for 1,531 services of 47 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 917 | 1,531 | 75 | 0.92 | $446,474 | $123,006 |
| 2023 | 534 | 812 | 74 | 1.00 | $190,295 | $52,490 |
| 2022 | 11 | 18 | 61 | 0.57 | $8,960 | $2,079 |
| 2021 | 15 | 27 | 68 | 0.54 | $12,868 | $3,082 |
| 2020 | 12 | 30 | 53 | 0.60 | $14,174 | $3,682 |
| 2018 | 412 | 3,227 | 73 | 1.42 | $198,035 | $52,340 |
| 2017 | 435 | 2,677 | 74 | 1.22 | $157,325 | $50,404 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 18 services
| Screening mammography | 60 | $10,240 | $171 |
| Dxa bone density measurement of hip, pelvis, spine | 78 | $3,948 | $51 |
| X-ray of chest, 2 views | 100 | $3,498 | $34 |
| X-ray of foot, minimum of 3 views | 64 | $3,483 | $36 |
| Complete ultrasound scan of abdomen | 27 | $3,331 | $123 |
| Screening 3d breast mammography | 38 | $2,524 | $66 |
| X-ray of knee, 4 or more views | 39 | $2,504 | $50 |
| Ultrasound scan of head and neck soft tissue | 14 | $1,670 | $119 |
| X-ray of shoulder, minimum of 2 views | 40 | $1,661 | $37 |
| Complete ultrasound scan behind abdominal cavity | 14 | $1,610 | $115 |
| X-ray of hip, 2-3 views | 25 | $1,513 | $50 |
| Diagnostic mammography of 1 breast | 11 | $1,460 | $133 |
| Complete ultrasound scan of pelvis | 11 | $1,136 | $103 |
| Limited ultrasound scan of 1 breast | 11 | $1,010 | $84 |
| X-ray of lower and sacral spine, 2-3 views | 21 | $894 | $43 |
| X-ray of ankle, minimum of 3 views | 16 | $674 | $40 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 12 | $638 | $53 |
| X-ray of upper spine, 2-3 views | 12 | $506 | $42 |
2018: 18 services
| Screening mammography | 33 | $5,852 | $177 |
| Mri scan of leg joint without contrast | 26 | $4,011 | $138 |
| Mri scan of lower spinal canal without contrast | 26 | $3,269 | $126 |
| Mri scan of brain without contrast | 16 | $2,466 | $154 |
| Mri scan of arm joint without contrast | 12 | $2,047 | $171 |
| Complete ultrasound scan of abdomen | 23 | $2,017 | $88 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 18 | $1,769 | $98 |
| Complete ultrasound scan of pelvis | 19 | $1,444 | $76 |
| Complete ultrasound scan behind abdominal cavity | 15 | $1,374 | $92 |
| Limited ultrasound scan of abdomen | 19 | $1,193 | $63 |
| X-ray of knee, 3 views | 35 | $1,039 | $20 |
| Dxa bone density measurement of hip, pelvis, spine | 14 | $728 | $52 |
| X-ray of chest, 2 views | 47 | $589 | $12 |
| X-ray of hand, minimum of 3 views | 18 | $567 | $19 |
| X-ray of lower and sacral spine, minimum of 4 views | 13 | $317 | $24 |
| X-ray of shoulder, minimum of 2 views | 18 | $317 | $14 |
| X-ray of foot, minimum of 3 views | 13 | $312 | $17 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 16 | $142 | $0 |
2017: 16 services
| Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (cad) when performed | 41 | $7,142 | $174 |
| Complete ultrasound scan of abdomen | 49 | $5,706 | $114 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 20 | $2,450 | $117 |
| X-ray of chest, 2 views, front and side | 80 | $1,926 | $23 |
| X-ray of knee, 3 views | 36 | $1,786 | $34 |
| Ct scan of abdomen and pelvis without contrast | 12 | $1,652 | $127 |
| Complete ultrasound scan behind abdominal cavity | 17 | $1,597 | $94 |
| Limited ultrasound scan of abdomen | 18 | $1,560 | $82 |
| Dxa bone density measurement of hip, pelvis, spine | 29 | $1,525 | $53 |
| Complete ultrasound scan of pelvis | 13 | $1,294 | $100 |
| X-ray of lower and sacral spine, minimum of 4 views | 27 | $1,112 | $41 |
| X-ray of foot, minimum of 3 views | 25 | $960 | $27 |
| X-ray of hand, minimum of 3 views | 20 | $937 | $30 |
| X-ray of hip, 2-3 views | 12 | $508 | $42 |
| X-ray of shoulder, minimum of 2 views | 19 | $501 | $25 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 23 | $186 | $0 |
Medicaid work
$210,731 in 2024
Medicaid paid $210,731 for 3,441 billed services this clinician did in 2024, up to 111 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation plus detailed fetal anatomic examination, transabdominal approach; single or first gestation | 1,145 | $95,265 |
| Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, first trimester (< 14 weeks 0 days), transabdominal approach; single or first gestation | 1,145 | $51,674 |
| Ultrasound, pregnant uterus, real time with image documentation, first trimester fetal nuchal translucency measurement, transabdominal or transvaginal approach; single or first gestation | 516 | $34,650 |
| Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, after first trimester (> or = 14 weeks 0 days), transabdominal approach; single or first gestation | 347 | $18,451 |
| Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 273 | $9,868 |
| Ultrasound, pregnant uterus, real time with image documentation, follow-up (eg, re-evaluation of fetal size by measuring standard growth parameters and amniotic fluid volume, re-evaluation of organ system(s) suspected or confirmed to be abnormal on a previous scan), transabdominal approach, per fetus | 15 | $824 |
| 2024 | 3,441 | 6 | 111 | $210,731 |
| 2023 | 3,860 | 6 | 130 | $275,850 |
| 2022 | 5,737 | 6 | 154 | $390,868 |
| 2021 | 6,386 | 6 | 153 | $424,784 |
| 2020 | 4,830 | 6 | 113 | $344,854 |
| 2019 | 5,320 | 6 | 124 | $393,170 |
| 2018 | 5,702 | 14 | 135 | $404,441 |
See the largest Medicaid services in earlier years
2023
| Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation plus detailed fetal anatomic examination, transabdominal approach; single or first gestation | 1,358 | $134,506 |
| Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, first trimester (< 14 weeks 0 days), transabdominal approach; single or first gestation | 1,264 | $64,529 |
| Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, after first trimester (> or = 14 weeks 0 days), transabdominal approach; single or first gestation | 520 | $31,694 |
| Ultrasound, pregnant uterus, real time with image documentation, first trimester fetal nuchal translucency measurement, transabdominal or transvaginal approach; single or first gestation | 341 | $28,308 |
| Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 235 | $11,318 |
| Ultrasound, pregnant uterus, real time with image documentation, follow-up (eg, re-evaluation of fetal size by measuring standard growth parameters and amniotic fluid volume, re-evaluation of organ system(s) suspected or confirmed to be abnormal on a previous scan), transabdominal approach, per fetus | 142 | $5,496 |
2022
| Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation plus detailed fetal anatomic examination, transabdominal approach; single or first gestation | 1,731 | $169,821 |
| Ultrasound, pregnant uterus, real time with image documentation, first trimester fetal nuchal translucency measurement, transabdominal or transvaginal approach; single or first gestation | 1,183 | $83,425 |
| Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, first trimester (< 14 weeks 0 days), transabdominal approach; single or first gestation | 1,578 | $77,329 |
| Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, after first trimester (> or = 14 weeks 0 days), transabdominal approach; single or first gestation | 541 | $31,488 |
| Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 313 | $16,022 |
| Ultrasound, pregnant uterus, real time with image documentation, follow-up (eg, re-evaluation of fetal size by measuring standard growth parameters and amniotic fluid volume, re-evaluation of organ system(s) suspected or confirmed to be abnormal on a previous scan), transabdominal approach, per fetus | 391 | $12,783 |
2021
| Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation plus detailed fetal anatomic examination, transabdominal approach; single or first gestation | 1,804 | $173,032 |
| Ultrasound, pregnant uterus, real time with image documentation, first trimester fetal nuchal translucency measurement, transabdominal or transvaginal approach; single or first gestation | 1,304 | $89,005 |
| Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, first trimester (< 14 weeks 0 days), transabdominal approach; single or first gestation | 1,550 | $76,193 |
| Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, after first trimester (> or = 14 weeks 0 days), transabdominal approach; single or first gestation | 826 | $48,168 |
| Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 362 | $20,465 |
| Ultrasound, pregnant uterus, real time with image documentation, follow-up (eg, re-evaluation of fetal size by measuring standard growth parameters and amniotic fluid volume, re-evaluation of organ system(s) suspected or confirmed to be abnormal on a previous scan), transabdominal approach, per fetus | 540 | $17,920 |
2020
| Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation plus detailed fetal anatomic examination, transabdominal approach; single or first gestation | 1,227 | $136,663 |
| Ultrasound, pregnant uterus, real time with image documentation, first trimester fetal nuchal translucency measurement, transabdominal or transvaginal approach; single or first gestation | 1,022 | $76,078 |
| Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, first trimester (< 14 weeks 0 days), transabdominal approach; single or first gestation | 1,002 | $48,540 |
| Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, after first trimester (> or = 14 weeks 0 days), transabdominal approach; single or first gestation | 755 | $48,106 |
| Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 366 | $19,896 |
| Ultrasound, pregnant uterus, real time with image documentation, follow-up (eg, re-evaluation of fetal size by measuring standard growth parameters and amniotic fluid volume, re-evaluation of organ system(s) suspected or confirmed to be abnormal on a previous scan), transabdominal approach, per fetus | 458 | $15,571 |
2019
| Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation plus detailed fetal anatomic examination, transabdominal approach; single or first gestation | 1,292 | $149,223 |
| Ultrasound, pregnant uterus, real time with image documentation, first trimester fetal nuchal translucency measurement, transabdominal or transvaginal approach; single or first gestation | 1,348 | $109,208 |
| Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, after first trimester (> or = 14 weeks 0 days), transabdominal approach; single or first gestation | 914 | $54,056 |
| Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, first trimester (< 14 weeks 0 days), transabdominal approach; single or first gestation | 1,005 | $50,576 |
| Ultrasound, pregnant uterus, real time with image documentation, follow-up (eg, re-evaluation of fetal size by measuring standard growth parameters and amniotic fluid volume, re-evaluation of organ system(s) suspected or confirmed to be abnormal on a previous scan), transabdominal approach, per fetus | 543 | $18,443 |
| Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 218 | $11,665 |
2018
| Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation plus detailed fetal anatomic examination, transabdominal approach; single or first gestation | 1,395 | $162,896 |
| Ultrasound, pregnant uterus, real time with image documentation, first trimester fetal nuchal translucency measurement, transabdominal or transvaginal approach; single or first gestation | 935 | $73,367 |
| Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, first trimester (< 14 weeks 0 days), transabdominal approach; single or first gestation | 1,114 | $60,713 |
| Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, after first trimester (> or = 14 weeks 0 days), transabdominal approach; single or first gestation | 847 | $45,923 |
| Ultrasound, pregnant uterus, real time with image documentation, follow-up (eg, re-evaluation of fetal size by measuring standard growth parameters and amniotic fluid volume, re-evaluation of organ system(s) suspected or confirmed to be abnormal on a previous scan), transabdominal approach, per fetus | 1,000 | $40,405 |
| Service | 58 | $6,662 |
| Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 79 | $4,946 |
| Service | 81 | $4,431 |
| New patient visit (30+ min) | 40 | $1,849 |
| OFFICE CONSULTATION | 50 | $1,270 |
| Short return visit (20+ min) | 62 | $1,221 |
| Ultrasound by transvaginal approach | 13 | $264 |
Money from drug and device companies
$96 in 2025
| 2025 | 1 | 1 | None | $96 |
| 2019 | 1 | 1 | None | $22 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novo Nordisk | Wegovy | $96 | 1 payment
|
See the published payment
| Novo Nordisk | Meals · 2025-03-28 | Wegovy | $96 |
See earlier years (2019)
2019: $22
| Roche Diagnostics | Rs Harmony Test Related Products | $22 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 83.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1437170024
- Licence
- CA G84844California G84844: Current · expires 2027-12-31
- Trained
- Boston University School of Medicine, 1993
- Group
- Foundation Radiology Group PC · El Camino Health Medical Network LLC
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G848440
- Taxonomy
- Diagnostic radiology (2085R0202X)
- Mailing address
- 1580 W El Camino Real Ste 101, Mountain View, CA, 94040
- NPI first listed
- 2006-07-21
- NPI last updated
- 2015-11-13
This is when the NPI record was last certified, not a medical board exam.